Effect of short term CPAP therapy in obstructive sleep apnea patients with metabolic syndrome

Journal of Clinical and Diagnostic Research

Volumn 9, Issue 4, 2015, Pages CC07-CC10

  Kanimozhi, S ^a   Balaji, C ^a   Saravanan, A ^a   Ravi, K ^b  

^a SRM UNIVERSITY   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Blood pressure; Insulin resistance; Lipid profile; Oxidative stress

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; SLEEP DISORDERED BREATHING;

EID: 84926486504     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2015/13301.5859     Document Type: Article

References (38)

1. Lam JCM, Lam B, Lam CL, et al. Obstructive sleep apnea and the metabolic syndrome in community-based Chinese subjects in Hong Kong. Respir Med. 2006;100:980-87.
2. Sharma SK, Kumpawat S, Banga A, Goel A. Prevalence and risk factors of obstructive sleep apnea syndrome in a population of Delhi, India. Chest. 2006;130:149-56.
3. Sharma SK, Reddy EV, Sharma A, Kadhiravan T, Mishra HK, Sreenivas V, et al. Prevalence and risk factors of syndrome Z in urban Indians. Sleep Med. 2010;11:562-68.
4. Agrawal S, Sharma SK, Sreenivas V, Lakshmy R. Prevalence of metabolic syndrome in a north Indian hospital-based population with obstructive sleep apnoea. Indian J Med Res. 2011;134:639-44.
5. Suzuki YJ, Jain V, Park AM, Day RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med. 2006;40:1683-12.
6. Singh TD, Patial K, Vijayan VK, Ravi K. Oxidative stress and obstructive sleep apnoea syndrome. Indian J Chest Dis Allied Sci. 2009;51:217-24.
7. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364:656-65.
8. Fleetham J, Ayas N, Bradley D, CTS Sleep Disordered Breathing Committee, et al. Canadian Thoracic Society guidelines: diagnosis and treatment of sleep disordered breathing in adults. Can Respir J. 2006;13:387-92.
9. Durán-Cantolla J, Aizpuru F, Montserrat JM, et al. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. BMJ. 2010;341:c5991.
10. Harsch IA, Schahin SP, Redespiel-Tr.ger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004;69:156-62.
11. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax. 2004;59:777-82.
12. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540-45.
13. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA. 2001;285:2486-97.
14. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363: 157-63.
15. Philips P, Kryger M. Management of obstructive sleep apnoea-hypopnea syndrome: overview. In: Kryger M, editor Principles and Practice of Sleep Medicine. Philadelphia: Elsevier 2006;1109-21.
16. Iber C, Ancoli-Israel S, Chesson A, et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications; 1st edition Westchester: American Academy of Sleep Medicine, 2007.
17. Arkansas Center for Health Improvement. A Training Manual for Height and Weight Assessment. Available at: http://www.achi.net.Manual.pdf. Accessed November 2010.
18. British hypertension society guidelines. Available at:http://guidance.nice.org.uk/CG127/NICEGuidance/pdf/English.
19. Stadtman TC. Preparation and assay of cholesterol and ergosterol. Methods in Enzymology. 1957;3(63):392-94.
20. Friedwald WT, Levy RI, Fredrickson DS, et al. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
21. Walker HK, Hall W and Hurst JW. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. 1990. Chapter 141.Boston: Butterworths;. Available from: http://www.ncbi.nlm.nih.gov/books/NBK248/.
22. Bonger A, Garica-Webb P. C-Peptide measurement: Methods and clinical utility. Critical Reviews in Clinical Laboratory Science. 1984;19:297.
23. Katsuki A, Sumida Y. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care. 2001;24:362-65.
24. Dousset J, Trouilh M, Foglietti M. Plasma malonaldehyde levels during myocardial infarction. Clin Chim Acta. 1983;129:319-22.
25. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:(1):70-77.
26. Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol. 1994;233:380-85.
27. Selim B, Won C, Yaggi HK. Cardiovascular consequences of sleep apnea. Clin Chest Med. 2010;31(2):203-20.
28. Alzoghaibi MA, Bahammam AS. The effect of one night of continuous positive airway pressure therapy on oxidative stress and antioxidant defense in hypertensive patients with severe obstructive sleep apnea. Sleep Breath. 2012;Jun;16(2):499-504.
29. Parish JM, Adam T, Facchiano L. Relationship of Metabolic Syndrome and Obstructive Sleep Apnea. J Clin Sleep Med. 2007;3(5):467-472.
30. Jelic S, Le Jemtel TH. Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea. Trends Cardiovasc Med. 2008;18(7):253-60.
31. Ip MS, Lam B, Ng MM, Lam WK, Tsant KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165:670-76.
32. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and Type 2 diabetes. Thorax. 2007;62(11):969-74.
33. Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L, Chaturvedi P. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med. 2007;8:12-17.
34. Li J, Thorne LN, Punjabi NM, et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res. 2005;97:698-706.
35. Lévy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J. 2009;34:243-60.
36. Kono M, Tatsumi K, Saibara T, et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest. 2007;131:1387-92.
37. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176:706-12.
38. Sharma SK, Agarwal S, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med. 2011;365:2277-86.